AHA Coding Clinic® for ICD-9 - 2011 Issue 1; Ask the Editor
Pancytopenia due to Drug
There has been some confusion about coding drug-induced pancytopenia. Coding Clinic advised how to code chemotherapy induced aplastic anemia but did not address pancytopenia secondary to drugs. In ICD-9-CM, pancytopenia is indexed to code 284.1, Pancytopenia. However, code 284.1 is excluded from pancytopenia due to or with aplastic anemia (284.9) as well as that which is drug induced (284.89). If the provider documents “pancytopenia due to chemotherapy†and there is no documentation of “aplastic anemia,†how is this coded? ...
Subscribe or sign in to view the full article.
Article Overview
This article discusses a coding question involving pancytopenia documented in connection with drug exposure, and places it in the context of prior Coding Clinic guidance and ICD-9-CM instructional notes. It is intended for coders, auditors, compliance staff, and other revenue cycle professionals who need to understand how the issue is framed in the source guidance.
Why This Topic Matters
Pancytopenia documented with drug exposure can raise coding ambiguity when related hematologic terminology is also present. This article helps readers understand the scope of the discussion and the coding references involved.
What You Will Learn
- How the article frames drug-associated pancytopenia as a coding issue
- What prior guidance is referenced in relation to chemotherapy-associated blood disorders
- How the article situates the question within ICD-9-CM instructional language and exclusions
- Why documentation wording is important to the topic discussed
Who Should Read This
- Medical coders
- Coding auditors
- Compliance professionals
- Revenue cycle staff
- Clinical documentation improvement specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com